I-131
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for I-131, covering 2021-11-04 to 2021-11-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma [Phase 2]